Remsima Powder for Concentrate for Solution for Infusion

Remsima Powder for Concentrate for Solution for Infusion

Category: Drug Info

Specifications
Details

Manufacturer
Celltrion, Inc.(KOREA,SOUTH)

Registraction Number
MAL15015118ACRZ


Content:
  • Active Ingredient: Infliximab (biosimilar)
  • Excipients: Various inactive ingredients to stabilize the powder
Indications:
  • Crohn's Disease: Used to reduce signs and symptoms and induce and maintain remission.
  • Ulcerative Colitis: Used to induce and maintain remission.
  • Rheumatoid Arthritis: Used to reduce signs and symptoms, inhibit the progression of structural damage, and improve physical function.
  • Ankylosing Spondylitis: Used to reduce signs and symptoms.
  • Psoriatic Arthritis: Used to reduce signs and symptoms.
  • Plaque Psoriasis: Used to reduce the signs and symptoms of severe plaque psoriasis in adults who have not responded to other systemic therapies.
Instructions:
  1. Dosage and Administration: The dosage and administration should be determined by a healthcare provider based on the specific medical condition and patient needs. It is typically administered via intravenous infusion.
  2. Storage: Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
  3. Handling: Use aseptic techniques to avoid contamination. Dispose of syringes and needles safely after use.
  4. Monitoring: Regular monitoring of the patient's condition and any potential side effects as advised by the healthcare provider.

View more about Remsima Powder for Concentrate for Solution for Infusion on main site